News from Zyme and the companies we work with.
Big Picture Bio founded to identify, design and optimise promising cancer combination therapies
New company founded by Deep Science Ventures veterans closes £1.5M (~$2M USD) pre-seed round and secures £700K (~$950K USD) Innovate UK funding Founding team and advisors bring expertise from Deep [...]
Fuse Diagnostics raises £1 million to scale rapid point-of-need molecular testing platform
Financing will accelerate commercialisation of Fuse Diagnostics’ proprietary Flip platform, expanding its portfolio of rapid, laboratory-quality molecular diagnostics for high-value industrial and life science applications Investment led by The FSE [...]
EpilepsyGTx and Viralgen collaborate to advance AAV gene therapy programme for epilepsy ahead of first-in-human trial
Collaboration with AAV-specialist CDMO will support scalable production of EPY201 for focal refractory epilepsy affecting 10 million people London, UK and San Sebastián, Spain – 9 SEPTEMBER 2026: EpilepsyGTx, a [...]
Eppendorf launches new refrigerated Centrifuge 5811 R
Hamburg, Germany, 8 September, 2026 – Eppendorf, a leading international life science company that develops, manufactures, and distributes instruments, consumables, and services for use in laboratories around the world, today [...]
OutSee awarded Innovate UK grant for agentic AI pilot study to enhance drug target validation
Pilot study to develop prototype agentic AI sub-system for initial validation screening of targets identified using AI predictive genomics platform, Nomaly Funding provided jointly by Innovate UK and Empirical Ventures [...]
Bio-Rad Expands Foresight Pro Prepacked Chromatography Columns with Nuvia Ion Exchange and Mixed-Mode Resins for Biomanufacturing
Extended Range of Process-Scale Columns Prepacked with CEX, AEX, CEX-HIC, and AEX-HIC Chromatography Resins Provides an Effective Solution for Purification of Biomolecules in Downstream Processing HERCULES, Calif.—September 01, 2026—Bio-Rad Laboratories, [...]
Carterra Enables Anthropic’s Autonomous AI Protein Design Study via its HT-SPR Binding Platforms
Salt Lake City, Utah, August 24, 2026: Carterra®, a leading provider of high-throughput surface plasmon resonance (HT-SPR) platforms for antibody and small molecule drug discovery, today highlighted the role of [...]
FairJourney Bio delivers antibody engineering for novel tumor-conditional IL-12 therapeutic approach that unlocks the potential of localized cytokine activation
Study in mAbs describes the first reported demonstration of a reversible trans-activation logic gate for tumor-conditional cytokine delivery FJBio engineered dual-specificity Fabs to meet model-defined affinity window through an end-to-end [...]
Qureight expands with addition of second site, to accommodate rapid growth and ongoing development of chest Foundation Model
Investment in new premises in London reflects significant milestone in Company’s growth, following $20 million Series B financing Supports rapid scale-up and development of foundational AI imaging model, to improve [...]
Tagomics introduces LiquiPath, a first-in-class cfDNA-based blood test for multi-organ drug safety monitoring
Non-invasive cell-free DNA liquid biopsy platform for multi-organ monitoring of drug-safety across preclinical and clinical settings Early access programme now open for drug developers to shape future platform capabilities and [...]
SynGenSys introduces expanded CHO.SET synthetic promoter library for enhanced biomanufacturing
CHO.SET® 2.0 library of synthetic promoters provide tuneable expression of transgenes whilst maximising CHO cell productivity CHO.SET® promoters enable higher protein titres, reduced costs and shorter development timelines Sheffield, UK, [...]
CN Bio awarded Innovate UK grant to reduce animal use in pharmacokinetic studies
Grant funding delivered in partnership with the NC3Rs, in support of UK Government roadmap to reduce animal testing by 2030 Project to develop standardized workflow to more accurately predict drug [...]
